Skip to main content
Brainsway Ltd. logo

Brainsway Ltd. — Investor Relations & Filings

Ticker · BWAY ISIN · IL0011007189 TA Manufacturing
Open in API
Filings indexed 375 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country IL Israel
Listing TA BWAY

About Brainsway Ltd.

https://www.brainsway.com/

Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Regulatory Filings
2026-04-21 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The text is a short immediate report notice (1,902 characters) under Israeli periodic and immediate reporting rules, stating that “Attached hereto is a report on BrainsWay Form S-8 2019 Plan” with a PDF file name. It does not contain the full report itself but announces its publication and attachment. Under the “menu vs meal” rule, this is a report publication announcement, not the actual S-8 filing.
2026-04-21 English
Other Report or Announcement
Regulatory Filings
2026-04-21 Hebrew (modern)
Other Report or Announcement
Transaction in Own Shares Classification · 1% confidence The document is an immediate report filed via the Israel Securities Authority and Tel Aviv Stock Exchange (“MAGNA”) under Regulation 5 (Periodic and Immediate Reports of a Foreign Corporation). It attaches a BrainsWay Form S-8 POS (“BWAY_Form_S-8_POS_isa.pdf”), which is a US SEC registration statement for issuing the company’s own shares under an employee benefit plan. This is not a financial result release or an AGM/annual report but a share‐issuance filing. According to the taxonomy, this best matches the “Transaction in Own Shares” category (POS).
2026-04-21 English
Report of Periodic or Interim Report
Regulatory Filings
2026-04-21 Hebrew (modern)
Report of Periodic or Interim Report
Report Publication Announcement Classification · 1% confidence The document is an Israeli TASE/ISA filing announcing the scheduled publication and attaching the BrainsWay 2025 Form 20-F. It is short, states that the report is attached, and provides reference details rather than the full report content. Under the “menu vs meal” rule, this constitutes a Report Publication Announcement rather than the report itself.
2026-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.